Quick Order Cart

Cat. No. ARG27447

C2CD3 Knockout HAP1 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Bone Marrow

  • Disease:

    Chronic myeloid leukemia

The C2CD3 Knockout HAP1 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from the near-haploid HAP1 cell line, targeting the C2CD3 gene. C2CD3 is a critical regulator of centriole elongation and ciliogenesis, functioning at the distal centriole to recruit OFD1, CEP120, and CPAP, and its loss disrupts Hedgehog signaling. This loss-of-function model is a powerful tool for investigating ciliopathy mechanisms, including orofaciodigital syndrome type 14 and Joubert syndrome. It supports applications in centrosome biology, ciliary signaling, and disease modeling through assays such as immunofluorescence, ciliogenesis assays, western blotting, and Hedgehog reporter analysis.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HAP1

    Sex of Donor

    Male

    Age

    40 years

    Derived From Site

    Bone marrow

    Gene Name

    C2CD3

    Gene Identifier

    NCBI Gene ID 26005

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    IMDM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The C2CD3 Knockout HAP1 Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population targeting the C2CD3 gene. This engineered pool of HAP1 cells carries heterogeneous gene disruptions, providing a loss-of-function model that avoids single-clone artefacts while enabling robust investigation of C2CD3-dependent processes. The polyclonal format preserves genetic diversity and is ideally suited for population-level functional genomics, pooled screening, and biochemical studies where clonal variability is undesirable. Researchers can exploit this model to dissect the cellular consequences of C2CD3 deficiency without the confounding effects of monoclonal selection.

The host HAP1 cell line is a near-haploid human cell line originally derived from KBM-7 chronic myeloid leukemia cells. Its near-haploid karyotype simplifies genetic manipulation and facilitates the generation of clear loss-of-function phenotypes, as most loci are present in a single copy. HAP1 cells retain expression of key ciliary and signaling components, making them a versatile and robust platform for studying pathways that intersect with centrosome biology and ciliogenesis. Their rapid proliferation and ease of culture further enhance their utility for high-throughput imaging, biochemical time courses, and CRISPR-based functional screens.

C2CD3 encodes a distal centriolar protein that is essential for centriole elongation and the initiation of ciliogenesis. It functions as a positive regulator of ciliary vesicle formation by recruiting OFD1, CEP120, and CPAP to the distal end of the mother centriole, thereby promoting assembly of the distal appendage and subsequent axoneme extension. C2CD3 also interacts with TALPID3, a centrosomal protein implicated in centriole maturation. The protein localizes downstream of Hedgehog signal transduction and is transcriptionally regulated by ciliogenic factors such as RFX3 and FOXJ1. In the absence of C2CD3, centriole elongation fails, ciliary vesicle docking is impaired, and Hedgehog signaling is disrupted, mirroring key pathogenic events in ciliopathies.

In the HAP1 near-haploid context, C2CD3 knockout creates a simplified genetic environment for dissecting the molecular hierarchy of centriole assembly and ciliary signaling. Because HAP1 cells rely on the same core centriolar machinery as other human cells, the knockout phenotype provides a tractable model for structure?Cfunction studies of distal centriole components. The loss-of-function background enables unambiguous assignment of C2CD3-dependent interactions and downstream signaling events. Moreover, the haploid nature may unmask recessive cellular defects that are masked in diploid models, offering a powerful complement to studies in primary cells or organoids.

This knockout model is particularly valuable for disease-modeling applications related to orofaciodigital syndrome type 14, Joubert syndrome, and broader centrosome-related ciliopathies. Experimental applications include immunofluorescence analysis of centriolar markers (e.g., CEP120, CPAP), ciliogenesis assays under serum-starvation conditions, western blotting for C2CD3 and its interaction partners, RT-qPCR profiling of ciliary gene expression, and Hedgehog reporter assays to quantify pathway activity. These cells are suitable for drug discovery screens targeting ciliogenesis or Hedgehog signaling, as well as for mechanistic studies of distal centriole biology. For further details or technical support, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)